MocFormer: A Two-Stage Pre-training-Driven Transformer for Drug–Target Interactions Prediction
-
Published:2024-06-26
Issue:1
Volume:17
Page:
-
ISSN:1875-6883
-
Container-title:International Journal of Computational Intelligence Systems
-
language:en
-
Short-container-title:Int J Comput Intell Syst
Author:
Zhang Yi-Lun,Wang Wen-Tao,Guan Jia-Hui,Jain Deepak Kumar,Wang Tian-Yang,Roy Swalpa Kumar
Abstract
AbstractDrug–target interactions is essential for advancing pharmaceuticals. Traditional drug–target interaction studies rely on labor-intensive laboratory techniques. Still, recent advancements in computing power have elevated the importance of deep learning methods, offering faster, more precise, and cost-effective screening and prediction. Nonetheless, general deep learning methods often yield low-confidence results due to the complex nature of drugs and proteins, bias, limited labeled data, and feature extraction challenges. To address these challenges, a novel two-stage pre-trained framework is proposed for drug–target interactions prediction. In the first stage, pre-trained molecule and protein models develop a comprehensive feature representation, enhancing the framework’s ability to handle drug and protein diversity. This also reduces bias, improving prediction accuracy. In the second stage, a transformer with bilinear pooling and a fully connected layer enables predictions based on feature vectors. Comprehensive experiments were conducted using public datasets from DrugBank and Epigenetic-regulators datasets to evaluate the framework’s effectiveness. The results demonstrate that the proposed framework outperforms the state-of-the-art methods regarding accuracy, area under the receiver operating characteristic curve, recall, and area under the precision-recall curve. The code is available at: https://github.com/DHCGroup/MocFormer.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Berdigaliyev, N., Aljofan, M.: An overview of drug discovery and development. Future Med. Chem. 12(10), 939–947 (2020). https://doi.org/10.4155/fmc-2019-0307 2. Jourdan, J.-P., Bureau, R., Rochais, C., Dallemagne, P.: Drug repositioning: a brief overview. J. Pharm. Pharmacol. 72(9), 1145–1151 (2020). https://doi.org/10.1111/jphp.13273 3. Lim, H., Poleksic, A., Xie, L.: Exploring landscape of drug–target-pathway-side effect associations. AMIA Summits Transl. Sci. Proc. 2018, 132 (2018) 4. Himmat, M., Salim, N., Al-Dabbagh, M.M., Saeed, F., Ahmed, A.: Adapting document similarity measures for ligand-based virtual screening. Molecules 21(4), 476 (2016) 5. Vaswani, A., Shazeer, N., Parmar, N., Uszkoreit, J., Jones, L., Gomez, A.N., Kaiser, L.U., Polosukhin, I.: Attention is all you need. In: Proceedings of Advances in Neural Information Processing Systems, vol. 30 (2017)
|
|